Last reviewed · How we verify
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
This LIGHTSITE III study is a double-masked, sham-controlled, parallel design, prospective multi-site study for the use of PBM as a treatment for visual impairment in subjects with dry AMD.
Details
| Lead sponsor | LumiThera, Inc. |
|---|---|
| Phase | NA |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 96 |
| Start date | Sun Sep 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Dry Age-related Macular Degeneration
Interventions
- Valeda PBM treatment
- Valeda Sham treatment
Countries
United States